Incremental prognostic value of multichamber deformation imaging and renal function status to predict adverse outcome

Samir K Saha1, Xia-Xia Luo2,3, Aasha S Gopal4

  • 1Umeå University, Umeå, Sweden.

Insights

Biventricular and bi-atrial strain imaging, combined with renal function and pulmonary artery pressure, can predict adverse outcomes in heart failure with reduced ejection fraction. This multichamber approach offers valuable prognostic information for patients with heart failure.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Research

Background:

  • Deformation imaging of the heart is crucial in cardiology.
  • Limited data exist on biventricular/bi-atrial strain in heart failure with reduced ejection fraction (HFREF) and comorbidities.

Purpose of the Study:

  • To investigate the prognostic value of multichamber deformation imaging in HFREF.
  • To assess the association of cardiac strain, renal function, and pulmonary artery pressure with adverse outcomes.

Main Methods:

  • 49 HFREF patients and 14 controls underwent deformation imaging (LVGLS%, RVS%, LARS%).
  • Standard echocardiography (LVEF%, E/E', PASP) and renal function (creatinine) were assessed.
  • Logistic regression and ROC analysis evaluated predictors of death/hospitalization over 4.2 years.

Main Results:

  • HFREF patients showed significantly impaired LVGLS%, RVS%, and LARS% compared to controls.
  • Univariate analysis identified RVS%, E/E', and PASP as predictors of adverse events.
  • Multivariate analysis revealed only PASP as an independent predictor; however, LARS% combined with creatinine predicted mortality and hospitalization.

Conclusions:

  • Multichamber deformation imaging, renal function, and PASP are valuable for predicting adverse outcomes in HFREF.
  • Combining left atrial reservoir strain and renal function offers significant prognostic insight.
Abstract

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
498
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402